348 related articles for article (PubMed ID: 30088177)
1. Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database.
Bae SY; Kim SJ; Lee J; Lee ES; Kim EK; Park HY; Suh YJ; Kim HK; You JY; Jung SP
Breast Cancer Res Treat; 2018 Nov; 172(1):113-121. PubMed ID: 30088177
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
Bae SY; Jung SP; Jung ES; Park SM; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ
Oncology; 2018; 95(3):163-169. PubMed ID: 29913459
[TBL] [Abstract][Full Text] [Related]
3. Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.
Ryu JM; Yu J; Kim SI; Kim KS; Moon HG; Choi JE; Jeong J; Do Byun K; Nam SJ; Lee JE; Lee SK; Kim SW
Breast Cancer Res Treat; 2017 Dec; 166(3):833-842. PubMed ID: 28831642
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China.
Han BY; Li XG; Zhao HY; Hu X; Ling H
BMC Cancer; 2020 Mar; 20(1):244. PubMed ID: 32293328
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up.
Yang SX; Polley EC
Breast Cancer Res Treat; 2019 Jun; 175(2):287-295. PubMed ID: 30746635
[TBL] [Abstract][Full Text] [Related]
7. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.
Madaras L; Kovács KA; Szász AM; Kenessey I; Tőkés AM; Székely B; Baranyák Z; Kiss O; Dank M; Kulka J
Pathol Oncol Res; 2014 Jul; 20(3):581-90. PubMed ID: 24357159
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology.
Jung HA; Park YH; Kim M; Kim S; Chang WJ; Choi MK; Hong JY; Kim SW; Kil WH; Lee JE; Nam SJ; Ahn JS; Im YH
Tumour Biol; 2015 Feb; 36(2):1073-9. PubMed ID: 25326808
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and recurrence patterns according to breast cancer subtypes in Korean women.
Lee Y; Kang E; Lee AS; Baek H; Kim EK; Park SY; Kim JH; Kim YJ; Kim SH; Kim IA; Eom KY; Kim SW
Breast Cancer Res Treat; 2015 May; 151(1):183-90. PubMed ID: 25893592
[TBL] [Abstract][Full Text] [Related]
11. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database.
Hwang KT; Kim EK; Jung SH; Lee ES; Kim SI; Lee S; Park HK; Kim J; Oh S; Kim YA;
Breast Cancer Res Treat; 2018 Jun; 169(2):311-322. PubMed ID: 29383628
[TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
14. Defining breast cancer intrinsic subtypes by quantitative receptor expression.
Cheang MC; Martin M; Nielsen TO; Prat A; Voduc D; Rodriguez-Lescure A; Ruiz A; Chia S; Shepherd L; Ruiz-Borrego M; Calvo L; Alba E; Carrasco E; Caballero R; Tu D; Pritchard KI; Levine MN; Bramwell VH; Parker J; Bernard PS; Ellis MJ; Perou CM; Di Leo A; Carey LA
Oncologist; 2015 May; 20(5):474-82. PubMed ID: 25908555
[TBL] [Abstract][Full Text] [Related]
15. Behavior and Outcomes of Pregnancy Associated Breast Cancer.
Suleman K; Osmani AH; Al Hashem H; Al Twegieri T; Ajarim D; Jastaniyah N; Al Khayal W; Al Malik O; Al Sayed A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):135-138. PubMed ID: 30678424
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.
Liu J; Chen K; Jiang W; Mao K; Li S; Kim MJ; Liu Q; Jacobs LK
J Cancer Res Clin Oncol; 2017 Jan; 143(1):161-168. PubMed ID: 27704268
[TBL] [Abstract][Full Text] [Related]
18. Survival of women with pregnancy-associated breast cancer according to clinical characteristics: A propensity score matching study.
Gwak H; Woo SS; Lee ES; Park MH; Lee S; Youn HJ; Park S; Suh IS; Kim SH
Medicine (Baltimore); 2022 Oct; 101(40):e30831. PubMed ID: 36221366
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile.
Suelmann BBM; van Dooijeweert C; van der Wall E; Linn S; van Diest PJ
Breast Cancer Res Treat; 2021 Apr; 186(3):699-704. PubMed ID: 33635448
[TBL] [Abstract][Full Text] [Related]
20.
Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
